Hua Medicine (Shanghai) Ltd.
HUMDF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 41.9% | 49.3% | 1,535% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 54.2% | 50.2% | 46.5% | -106.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -30% | -108.4% | -189.2% | -3,251.7% |
| Other Income/Exp. Net | $1 | $0 | $0 | $0 |
| Pre-Tax Income | $1 | -$0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $1 | -$0 | -$0 | -$0 |
| % Margin | 544.5% | -70.4% | -138.6% | -1,929.3% |
| EPS | 1.2 | -0.11 | -0.145 | -0.124 |
| % Growth | 1,192.9% | 24.3% | -17.3% | – |
| EPS Diluted | 1.2 | -0.11 | -0.145 | -0.124 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -26.7% | -104% | -181.9% | -3,125.4% |